Windlas Biotech has delivered steady growth - sales up 75% in 3 yrs, EPS nearly doubled, and margins stable at 12-13%. Analyst Finkhoz pegs strong support near ₹925 and resistance at ₹1,025. A breakout above ₹1,025 could trigger a Cup & Handle rally towards ₹1,160-1,350. Until then, remains a "buy-on-dips" play.